Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medicure Inc V.MPH

Alternate Symbol(s):  MCUJF

Medicure Inc. is a pharmaceutical company. It is focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market. The focus of it is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through the Company's United States subsidiary, Medicure Pharma Inc. It also operates Marley Drug Inc. (Marley Drug), a pharmacy subsidiary servicing all 50 states, Washington D.C. and Puerto Rico. Marley Drug is committed to improving access to medication for all Americans together with exceptional customer service and free home delivery. AGGRASTAT is indicated to reduce the rate of thrombotic cardiovascular events in patients with non-ST elevation acute coronary syndrome. It also develops pyridoxal 5'-phosphate analogues (P5P Analogues), the processes for their preparation, compositions containing P5P Analogues.


TSXV:MPH - Post by User

Bullboard Posts
Comment by ArbProfiton Nov 06, 2019 10:11am
138 Views
Post# 30315232

RE:Unusual Trading Activity

RE:Unusual Trading Activity
TheRock077 wrote: So, why is someone selling nearly $2 below the buyback price ?



Because the tender offer is likely to be significantly oversubscribed. 

They are buying back 4 million shares.

There are two shareholders that together own 6 million shares.

If they tender their shares, which is likely, you'll only get a prorated number of shares sold at $6.50.

When the tender offer documents are available, check to see what they say about significant shareholders.  They usually disclose if the major shareholder do not plan to tender.  If nothing is said, I assume they will.

This stock is also incredibly illiquid.  That means it's an opportunity for these two shareholders to sell, which is almost impossible for them in the open market.

If you believe that these shareholders will not tender their shares, it's a different story.
Bullboard Posts